Orléans, France

Isabelle Demuynck

This inventor holds 2 USPTO granted patents. Top assignee: Les Laboratoires Servier. Active years: 2008-2010.


% Patents Active = 50.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2008-2010

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Isabelle Demuynck

Introduction

Isabelle Demuynck is a prominent inventor based in Orleans, France. She has made significant contributions to the field of medicinal chemistry, particularly in the development of treatments for osteoporosis and arthrosis. With a total of 2 patents to her name, her work has garnered attention in the scientific community.

Latest Patents

Isabelle's latest patents include the alpha crystalline form of strontium ranelate. This innovative formulation is characterized by its powder X-ray diffraction diagram and a water content ranging from 22 to 24%. The medicinal products containing this formulation are particularly useful in the treatment of osteoporosis and arthrosis, showcasing her commitment to improving patient care.

Career Highlights

Isabelle Demuynck is associated with Les Laboratoires Servier, a well-respected company in the pharmaceutical industry. Her work at this organization has allowed her to focus on developing effective medicinal products that address critical health issues.

Collaborations

Throughout her career, Isabelle has collaborated with notable colleagues such as Stéphane Horvath and Gérard Damien. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Isabelle Demuynck's innovative work in medicinal chemistry and her contributions to the development of treatments for osteoporosis and arthrosis highlight her importance in the field. Her patents and collaborations reflect her dedication to improving health outcomes for patients.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…